These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Intravenous theophylline therapy. Effect of solubilizers on the incidence of adverse local effects in the area of infusion?]. Staib AH; Kyrein HJ Fortschr Med; 1984 Jun; 102(23):643-6. PubMed ID: 6469175 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the ordering of serum theophylline concentrations. Gentry SM; Keith TD; McMillan DM; Goetter WE Am J Hosp Pharm; 1981 Dec; 38(12):1937-9. PubMed ID: 7325177 [TBL] [Abstract][Full Text] [Related]
7. Prediction of steady state theophylline concentration during drug infusion. Johnson GF Iowa Med; 1984 Aug; 74(8):347-8, 350, 352. PubMed ID: 6490341 [No Abstract] [Full Text] [Related]
8. [The dose-concentration nomogram for intravenous theophylline therapy]. Awaya M; Ryuge K Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Sep; 20(9):957-66. PubMed ID: 7154445 [No Abstract] [Full Text] [Related]
9. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice. Arbab OA; Wiggins J; Ayres JG; Stableforth DE Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120 [TBL] [Abstract][Full Text] [Related]
11. Theophylline and its fickle unpredictability of absorption. Szefler SJ Ann Allergy; 1985 Oct; 55(4):580-3. PubMed ID: 3901834 [No Abstract] [Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels. van der Vet AP; Drost RH; Kreukniet J; Maes RA Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224 [TBL] [Abstract][Full Text] [Related]
13. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route]. Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461 [TBL] [Abstract][Full Text] [Related]
14. Poisoning patients with intravenous theophylline. Hendeles L; Weinberger M Am J Hosp Pharm; 1980 Jan; 37(1):49-50. PubMed ID: 7361773 [No Abstract] [Full Text] [Related]
15. [Serum levels and bronchodilatation after intravenous administration of theophylline in asthmatic patients]. Andrejak M; Lary H; Aubry P; Levi-Valensi P Rev Pneumol Clin; 1986; 42(2):82-6. PubMed ID: 3749701 [TBL] [Abstract][Full Text] [Related]
16. Early estimate of theophylline clearance during intravenous infusion. Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424 [TBL] [Abstract][Full Text] [Related]
20. Improved efficacy and safety of theophylline in the control of airways hyperreactivity. Hendeles L; Weinberger M Ann Allergy; 1982 Nov; 49(5):247-56. PubMed ID: 6128950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]